ANI PHARMACEUTICALS INC Annual Amortization of Intangible Assets in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Ani Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2012 to 2023.
  • Ani Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending September 30, 2024 was $13.9M, a 4.51% increase year-over-year.
  • Ani Pharmaceuticals Inc Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $53.3M, a 3.5% increase year-over-year.
  • Ani Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $52.3M, a 5.66% increase from 2022.
  • Ani Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $49.5M, a 18.4% increase from 2021.
  • Ani Pharmaceuticals Inc annual Amortization of Intangible Assets for 2021 was $41.8M, a 4.76% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $52.3M +$2.8M +5.66% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $49.5M +$7.7M +18.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $41.8M +$1.9M +4.76% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 $39.9M -$300K -0.75% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $40.2M +$8.5M +26.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-15
2018 $31.7M +$5M +18.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $26.7M +$5.3M +24.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $21.4M +$15.2M +245% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $6.2M +$2.9M +87.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $3.3M +$2.7M +450% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-02
2013 $600K +$550K +1100% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $50K Jan 1, 2012 Dec 31, 2012 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.